Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Dydrogesterone
(6-Dehydro-retro-progesterone)		[1] DYDROGESTERONE[1] Dydrogesterone 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬
2 Estradiol
(Estradiol and Progesterone)		[1] Estradiol[1] Estradiol 💬[2] ESR1,
ESR2 💬		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[7] 13, 46, 49, 65, 76, 226, 299 💬
3 Medroxyprogesterone acetate
(6α-Methyl-17-acetoxy progesterone)		[1] Medroxyprogesterone[1] Medroxyprogesterone acetate 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[8] 13, 35, 46, 49, 50, 51, 60, 107 💬
4 Megestrol acetate
(6-Methyl-17α-hydroxy-delta-progesterone acetate)		[1] Megestrol acetate[1] Megestrol acetate 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 76 💬
5 Progesterone [1] Progesterone[1] Progesterone 💬[1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[2] 76, 299 💬